CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Head & Neck Cancer

ONCOLOGY. Vol. 19 No. 3
 

Commentary (Ensley): Nutritional Support of Patients Undergoing Radiation Therapy for Head and Neck Cancer

The Colasanto/Prasad/Nash et al Article Reviewed

By John Ensley, MD1 | March 1, 2005
1Professor of Hematology/Oncology, Wayne State University School of Medicine; Professor of Medicine, Otolaryngology and Oncology; Chief, Head and Neck Cancer Section, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Perhaps no other group of malignancies is more severely affected by the problems patients have with establishing or maintaining good nutrition than those of the upper aerodigestive tract. Nutrition, or malnutrition, is a critical consideration during all phases of the diagnosis, treatment, and long-term management of patients with head and neck malignan cies, even following curative therapy.

This central consideration in the management of these patients is well reviewed by Colasanto et al in this issue of ONCOLOGY. Although the title suggests that the focus is only on patients undergoing radiation therapy, the review actually encompasses a broader discussion of the head and the impact of cytotoxic therapy on nutrition. The impact of surgery on nutrition is mentioned in the introduction, but the profound and lasting effects that surgical interventions can and do have in this group of patients is not extensively explored in the review. Also, the long-term effect of the tumor and its treatment, which may persist for a lifetime, is not discussed.

Head and Neck Cancer Patients

Indeed, malnutrition is one of comorbidities that many patients with head and neck cancer present with at the time of diagnosis.[1] The causes for this common state in this patient group are multifactorial, including social habits that preclude good nutritional habits (smoking, excess alcohol(Drug information on alcohol) consumption, poor oral hygiene and dental care) and other disease states such as chronic lung disease; gastrointestinal diseases such as gastritis, alcoholic bowel, liver, and pancreatic disease; as well as diabetes mellitus. Head and neck cancers, by definition, involve structures critical to mastication, taste, and deglutition. Therefore, the acquisition of these tumors is often accompanied by trismus, dysphasia and odynophagia, which add significantly to malnutrition, in conjunction with the common problems of anorexia and cachexia seen in patients with carcinomas in general.

Treatment of Head and Neck Cancer

Treatment modalities—surgery, radiotherapy, and chemotherapy—individually and collectively add to the problem of malnutrition. Increasingly, the regimens that have been shown to produce survival advantages or are successful in organ preservation produce increased acute and long-term toxicities, many of which have an impact on the patient's nutritional status. In addition to the trials reviewed in this article, standards for advancedstage, unresectable tumors,[2] organ preservation for advanced-stage laryngeal cancer,[3] and postoperative adjuvant treatment regimens[4] using concurrent radiotherapy and highdose cisplatinum have been recently reported from large-scale, randomized Intergroup phase III trials. These intense regimens can have profound effects on the patient's ability to chew, salivate, taste, swallow, aliment, and maintain nutrition.

Long-Term Sequelae

The head and neck cancer patient's lifestyle, damage from the tumor, and treatment all culminate in long-term sequelae that often affect nutritional status for a lifetime. In this review, the short-term strategies to correct malnutrition are discussed in depth. Long term strategies that include pharyngeal-esophageal dilatation, myomectomy,[ 5] intensive swallowing rehabilitation, and experimental approaches such as botulism toxin injections and salivary gland transposition[ 6] are often employed with inconsistent results. Indeed, some of the short-term solutions such as gastric and jejunal tubes become permanent, and the patient becomes "feeding tube-dependent."[7]

Following intensive swallowing rehabilitation, other patients may find ways to feed themselves without relying on alimentation tubes; however, they may never again gain pleasure from eating nor regain all the social ramifications that normal eating encompasses. While these patients may survive their tumors, their lives and quality of life are altered irrevocably. Concomitant with therapeutic advances that increase survival and organ preservation for patients with these tumors, the development of strategies for improved nutritional function and support is paramount.

Financial Disclosure: The authors have no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This commentary refers to the following article

Nutritional Support of Patients Undergoing Radiation Therapy for Head and Neck Cancer



JOSEPH M. COLASANTO, MD, PRIYAJIT PRASAD, MD, MARY ANN NASH, RD, ROY H. DECKER, MD, PhD and LYNN D. WILSON, MD, MPH


1. Kucuk O, Prasad A: Nutrients, phytocemicals and squamous cell carcinomas of the head and neck, in Ensley JF, Lippman S, Jacobs JR, et al (eds): Head and Neck Cancer: Emerging Perspectives. San Diego, Academic Press, 2002.
2. Adelstein DJ, Li Y, Adams G, et al: An Intergroup phase III comparison of standard radiation therapy (RT) and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer (SCHNC). J Clin Oncol 21:92-98. 2003.
3. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003.
4. Cooper JS, Pajak TF, Forastiere A, et al: Postoperative concurrent radiochemotherapy in high-risk squamous cell carcinoma of the head and neck: Initial report of RTOG 9501/Intergroup phase III trial. N Engl J Med 350:1937- 1944, 2004.
5. Jacobs JR, Logemann J, Pajak TF, et al: Failure of cricopharyngeal myotomy to improve dysphagia following head and neck cancer surgery. Arch Otolaryngol Head Neck Surg 125:942-946, 1999.
6. Jha N, Seikaly H, Harris J, et al: Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol 66:283- 289, 2003.
7. Al-Othman MO, Amdur RJ, Morris CG, et al: Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer? Head Neck 25:741-747, 2003.


 
RELATED CONTENT

Parotid Gland Swelling in 45-Year-Old Patient
May 6, 2013
Status of HPV-Related Cancers and Vaccination Trends
February 21, 2013
A 53-Year-Old Man Presents With Painful Neck Swelling
August 30, 2012
Laryngeal Mass Discovered in 46-Year-Old Man
July 23, 2012
Locoregional Recurrence of an HPV-Positive Squamous Cell Carcinoma of the Head and Neck
ONCOLOGY,  October 12, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Head And Neck Cancer
Evidence on Head And Neck Cancer
Guidelines on Head And Neck Cancer
Patient Education on Head And Neck Cancer
Clinical Trials on Head And Neck Cancer
Practical Articles on Head And Neck Cancer
Research and Reviews on Head And Neck Cancer
All "Head And Neck Cancer" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy